LONGO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 946
EU - Europa 792
AS - Asia 259
AF - Africa 1
SA - Sud America 1
Totale 1.999
Nazione #
US - Stati Uniti d'America 933
IE - Irlanda 243
SE - Svezia 228
CN - Cina 154
UA - Ucraina 103
SG - Singapore 90
DE - Germania 75
GB - Regno Unito 41
FI - Finlandia 33
IT - Italia 23
FR - Francia 19
CA - Canada 13
CZ - Repubblica Ceca 9
BE - Belgio 8
IN - India 7
RU - Federazione Russa 5
JP - Giappone 2
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
NO - Norvegia 1
SA - Arabia Saudita 1
TN - Tunisia 1
VN - Vietnam 1
Totale 1.999
Città #
Dublin 243
Jacksonville 203
Chandler 179
Nyköping 130
Singapore 77
Beijing 66
Ashburn 60
Princeton 37
Cambridge 32
Ann Arbor 31
Medford 31
Des Moines 30
Boardman 23
Woodbridge 23
Houston 15
Lancaster 15
San Mateo 14
Dearborn 13
Wilmington 13
Jinan 12
Nanjing 12
Ottawa 11
Brno 9
Brussels 8
Munich 7
Zhengzhou 7
Los Angeles 6
Seattle 6
Lanzhou 5
Messina 5
Ningbo 5
Shenyang 5
Haikou 4
Hangzhou 4
Hebei 4
Leawood 4
Santa Maria 4
Tianjin 4
Auburn Hills 3
Bremen 3
Guangzhou 3
Monmouth Junction 3
Nanchang 3
New York 3
Bengaluru 2
Changsha 2
Chicago 2
Clearwater 2
Falls Church 2
Hiroshima 2
Hyderabad 2
Jiaxing 2
Milan 2
Mumbai 2
Taizhou 2
Ardabil 1
Augusta 1
Bishkek 1
Bonnyville 1
Copenhagen 1
Dallas 1
Edinburgh 1
Fuzhou 1
Hanover 1
Helsinki 1
Jeffries 1
Kharkov 1
Mostar 1
Napoli 1
Norwalk 1
Novokuznetsk 1
Oslo 1
Phoenix 1
Qingdao 1
Rio de Janeiro 1
Rome 1
Saint Petersburg 1
San Francisco 1
Sciacca 1
Secaucus 1
Shenzhen 1
Stockholm 1
Taiyuan 1
Toronto 1
Twin Falls 1
Washington 1
Xi'an 1
Xiangfen 1
Yuanping 1
Zurich 1
Totale 1.432
Nome #
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 106
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 99
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 93
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 86
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 84
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 82
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 68
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 63
Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis 62
Calcio e secrezione endocrina pancreatica Nota III. Efffetti di una infusione di calcio sulla secrezione glucagonica da ipoglicemia insulinica. 62
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 59
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 57
Evidence for in vivo peroxynitrite production in human chronic hepatitis 56
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 55
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 55
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 54
Experimental colitis increases small intestine permeability in the rat 54
HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON 53
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 51
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 51
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 51
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 51
The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat 50
CHRONIC HEPATITIS IN PATIENTS WITH ACTIVE HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS COMBINED INFECTIONS - A HISTOLOGICAL STUDY 49
Omega-3 polyunsaturated fatty acids reduce bone loss in experimental colitis. 48
Mast cells mediate stress-induced loss of ileal tight junction (TJ)-permselectivity in the rat. 48
Feasibility, Tolerability and Efficacy of Carfilzomib, Lenalidomide and Desamethasone (KRD) in Relapsed Refractory Myeloma Patients: A Real-Life Survey of the Sicilian Myeloma Network 48
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 47
Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients 46
Hepatitis G virus in liver disease: Cause or case? 44
Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS. 44
HISTOLOGICAL FEATURES IN LIVER-BIOPSY SPECIMENS OF PATIENTS WITH ACUTE REACTIVATION OF CHRONIC TYPE-B HEPATITIS 41
OMEGA-3 POLYUNSATURATED FATTY ACIDS REDUCE BONE LOSS IN EXPERIMENTAL COLITIS. 38
Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease 36
Intestinal permeability test as a predictor of clinical course in Crohn's disease 32
Totale 2.023
Categoria #
all - tutte 8.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 0 0 0 0 17 41 52 3 57 43 1
2020/2021239 38 5 76 8 3 31 1 26 1 17 27 6
2021/2022253 1 32 10 10 4 0 10 9 2 73 28 74
2022/2023734 49 77 37 52 49 71 5 52 303 3 23 13
2023/2024123 9 20 11 32 18 11 1 4 0 4 4 9
2024/2025127 13 9 14 46 14 31 0 0 0 0 0 0
Totale 2.023